Clinical Trial: Dronabinol for Agitation in Dementia Crossover Trial
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Dementia Moderate
Study Type: INTERVENTIONAL
Official Title: Single-site, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Dronabinol for the Treatment of Agitation in Outpatient With Dementia
Brief Summary:
The goal of this clinical trial is to study the effects of dronabinol in US Veterans with agitation related to moderate to severe dementia.The main goals of the study are:To evaluate the efficacy of dronabinol for the treatment of agitation in moderate to severe dementia compared to placeboTo evaluate the safety of dronabinol in the treatment of agitation in moderate to severe dementia compared to placeboFifty (50) subjects will be given either dronabinol or placebo for 8 weeks.All subjects will then undergo a…
Read more